Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11500858 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL25432688 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| SCHEMBL548209 | 0.76 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL169726 | 0.75 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL6035050 | 0.74 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL2529839 | 0.73 | ALDH1A1 (0.43) | ALDH1A1TSHR | |
| SCHEMBL1489551 | 0.71 | LMNA (0.32) | ALDH1A1 | |
| SCHEMBL1489552 | 0.71 | LMNA (0.32) | ALDH1A1 | |
| SCHEMBL5477390 | 0.70 | HCAR2 (0.31) | — | |
| SCHEMBL230496 | 0.70 | ALDH1A1 (0.52) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101420923-A | Medical implant and fibrosis-inducing agent | ANGIOTECH INT AG (CH) | 2009-04-29 | — | — | CN | disclosed |
| CN-101227935-A | Compositions and methods for treating diverticulum disease | ANGIOTECH INT AG (CH) | 2008-07-23 | — | — | CN | disclosed |
| US-20070092483-A1 | Surgical adhesive compostion and process for enhanced tissue closure and healing | POLLOCK POLYMER GROUP | 2007-04-26 | — | — | US | disclosed |
| US-5350798-A | Cyanoacrylate and oxalic acid polyester | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1994-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092483-A1 | Surgical adhesive compostion and process for enhanced tissue closure and healing | MMP1, CTSF, OGFR | ALDH1A1 1498/4885TSHR 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.